- Home
- SPT vs ABEO Comparison
SPT vs ABEO Comparison
Compare SPT & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPT | ABEO |
|---|---|---|
| Founded | 2010 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 485.7M | 399.5M |
| IPO Year | 2019 | 2005 |
Fundamental Metrics
Financial Performance| Metric | SPT | ABEO |
|---|---|---|
| Price | $10.07 | $5.96 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | $11.75 | ★ $20.00 |
| AVG Volume (30 Days) | 1.2M | ★ 1.6M |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 32.11 | ★ 165.16 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $457,547,000.00 | $2,998,000.00 |
| Revenue This Year | $8.86 | $1,024.31 |
| Revenue Next Year | $8.04 | $145.42 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 12.72 | ★ 258.18 |
| 52 Week Low | $4.92 | $4.00 |
| 52 Week High | $16.03 | $7.65 |
Technical Indicators
Market Signals| Indicator | SPT | ABEO |
|---|---|---|
| Relative Strength Index (RSI) | 62.75 | 41.01 |
| Support Level | $9.19 | $5.00 |
| Resistance Level | $10.56 | $6.07 |
| Average True Range (ATR) | 0.49 | 0.33 |
| MACD | 0.04 | -0.12 |
| Stochastic Oscillator | 82.41 | 15.64 |
Price Performance
Historical ComparisonAbout SPT Sprout Social Inc
Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions. Geographically, the company operates in Americas, EMEA, and Asia Pacific, of which it derives maximum revenue from Americas.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.